| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Chemicals
|
Compare with Industry peers |
| Website | http://www.alufluoride.com | |
| Market Cap | 392.90 Cr. | |
| Enterprise Value(EV) | 409.83 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 20.22 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 24.84 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 46.81 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 101.14 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 4.97 | Calculated using Price: 502.40 |
| Dividend Yield | 0.40 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.78 Cr. | 7,820,482 Shares |
| FaceValue | 10 | |
| About Alufluoride Ltd. | ||
| Alufluoride started a project in 1993 for producing Aluminium Fluoride. The project was completed in record time at a cost of Rs 20 crore. Trial runs commenced in November 1994 and production of high quality commenced during December 1994. Supplies started immediately thereafter to primary aluminium smelters. The company increased production year after year at high quality standards. The company has an installed annual production capacity of 6000 tons of Aluminium Fluoride and plans to expand further. Alufluoride is the only company in Andhra Pradesh, producing Aluminium Fluoride (ALF3) with the modern Fluosilicic Acid technology developed by Alusuisse, Switzerland. | ||
| 1 Day |
|
-1.68% |
| 1 Week |
|
+0.76% |
| 1 Month |
|
+6.52% |
| 3 Month |
|
-3.07% |
| 6 Month |
|
+17.26% |
| 1 Year |
|
+57.67% |
| 2 Year |
|
+53.36% |
| 5 Year |
|
+328.39% |
| 10 Year |
|
+5990.91% |
| 3 years | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | -1.06 | 6.56 | 20.21 | |
| Return on Capital Employed (%) | -0.19 | 9.94 | 24.53 | |
| Return on Assets (%) | -0.58 | 3.62 | 11.67 |
| Particulars | 4 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 52 | 56 | 68 | 76 | |
| Non Curr. Liab. | 30 | 27 | 27 | 25 | |
| Curr. Liab. | 13 | 18 | 19 | 23 | |
| Minority Int. | 0 | 0 | |||
| Equity & Liab. | 95 | 100 | 114 | 124 | |
| Non Curr. Assets | 69 | 67 | 69 | 69 | |
| Curr. Assets | 26 | 33 | 45 | 55 | |
| Misc. Exp. not W/O | |||||
| Total Assets | 95 | 100 | 114 | 124 |
| Particulars | 4 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 39 | 88 | 136 | 154 | |
| Other Income | 1 | 1 | 1 | 2 | |
| Total Income | 39 | 89 | 137 | 156 | |
| Total Expenditure | -37 | -75 | -109 | -122 | |
| PBIDT | 2 | 14 | 28 | 34 | |
| Interest | -1 | -3 | -3 | -3 | |
| Depreciation | -3 | -6 | -7 | -8 | |
| Taxation | 1 | -1 | -5 | -7 | |
| Exceptional Items | |||||
| PAT | -1 | 4 | 12 | 15 | |
| Minority Interest | 0 | 0 | |||
| Share Associate | |||||
| Other Related Items | |||||
| Consolidated Net Profit | -1 | 4 | 13 | 16 | |
| Adjusted EPS | -1 | 5 | 16 | 20 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -2 | 4 | 20 | |
| Cash Fr. Inv. | -11 | -6 | -18 | |
| Cash Fr. Finan. | 16 | -5 | -2 | |
| Net Change | 2 | -7 | 1 | |
| Cash & Cash Eqvt | 8 | 2 | 2 |
|
Fri, 09 Feb 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 9Th February 2024 The Board of Directors at its meeting held today i.e. 9th February 2024 has inter alia approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2023. Accordingly we are enclosing herewith Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2023. These results have been subjected to limited review by statutory auditors who have expressed an unmodified review report. The Limited Review Report of the Statutory Auditors of the Company is enclosed herewith.The meeting of the Board of Directors of the Company commenced at 12.30 P.M. and concluded at 2.45 P.M.Kindly take the same on record. |
|
Fri, 09 Feb 2024
Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2023 The Board at its meeting held today i.e. 9th February 2024 has inter alia approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2023.We are enclosing herewith the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2023 along with the Limited Review Report from the Statutory Auditors. The meeting commenced at 12.30 PM and concluded at 14.45 PM. |
|
Wed, 31 Jan 2024
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2023. ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2023. |
| Wed, 24 Apr 2024 |
High Delivery Percentage
|
Closing Below Previous Low
|
Close Within 52 Week High Zone
|
High Increase in 1 Month
|
High Increase in 1 Year
|
